Bernd B{umlaut Over (u)}ttelmann

Title: **Bernd Büttelmann: Innovator in Hydroxymethylimidazodiazepines**

Introduction

Bernd Büttelmann is an accomplished inventor based in Schopfheim, Germany, known for his contributions to the field of pharmacology. With a focus on developing innovative compounds, his work has the potential to impact various medical applications.

Latest Patents

Bernd Büttelmann holds a patent related to hydroxymethylimidazodiazepines and their esters. This invention introduces a general formula I for these compounds, which can be utilized as anxiolytic, anticonvulsant, muscle relaxant, and sedative-hypnotic active substances. The implications of this invention are significant, as it addresses critical therapeutic needs.

Career Highlights

Currently, Büttelmann is associated with Hoffmann-La Roche Inc., where he continues to push the boundaries of pharmaceutical innovations. His research and development efforts have been instrumental in creating pharmaceutical solutions that enhance patient care and treatment outcomes.

Collaborations

Throughout his career, Bernd has collaborated with several talented individuals, including colleagues Rene Borer and Andre Szente. These partnerships have fostered a productive environment for creativity and innovation, leading to advancements in the pharmaceutical industry.

Conclusion

Bernd Büttelmann's work exemplifies the role of inventors in advancing medical science. His patent on hydroxymethylimidazodiazepines highlights the potential for new treatments that can significantly improve the quality of life for many patients. As he continues to innovate at Hoffmann-La Roche Inc., the medical field looks forward to his future contributions.